26B-4-212. Institutional review board — Approved study of cannabis, a cannabinoid product, or an expanded cannabinoid product.
| (1) |
As used in this section:
Terms Used In Utah Code 26B-4-212
| (a) |
“Approved study” means a medical research study:
| (i) |
the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and |
| (ii) |
that is approved by an IRB. |
|
| (b) |
“Board” means the Cannabis Research Review Board created in Section 26B-1-420. |
| (c) |
“Cannabinoid product” means the same as that term is defined in Section 58-37-3.6. |
| (d) |
“Cannabis” means the same as that term is defined in Section 58-37-3.6. |
| (e) |
“Expanded cannabinoid product” means the same as that term is defined in Section 58-37-3.6. |
| (f) |
“Institutional review board” or “IRB” means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services. |
|
| (2) |
A person conducting an approved study may, for the purposes of the study:
| (a) |
process a cannabinoid product or an expanded cannabinoid product; |
| (b) |
possess a cannabinoid product or an expanded cannabinoid product; and |
| (c) |
administer a cannabinoid product, or an expanded cannabinoid product to an individual in accordance with the approved study. |
|
| (3) |
A person conducting an approved study may:
| (a) |
import cannabis, a cannabinoid product, or an expanded cannabinoid product from another state if:
| (i) |
the importation complies with federal law; and |
| (ii) |
the person uses the cannabis, cannabinoid product, or expanded cannabinoid product in accordance with the approved study; or |
|
| (b) |
obtain cannabis, a cannabinoid product, or an expanded cannabinoid product from the National Institute on Drug Abuse. |
|
| (4) |
A person conducting an approved study may distribute cannabis, a cannabinoid product, or an expanded cannabinoid product outside the state if:
| (a) |
the distribution complies with federal law; and |
| (b) |
the distribution is for the purposes of, and in accordance with, the approved study. |
|
Renumbered and Amended by Chapter 307, 2023 General Session
